Glaxosmithkline reported GBP60.15B in Assets for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Amgen AMGN:US USD 65.12B 1.42B
AstraZeneca AZN:LN USD 96.48B 2.3B
Aurora Cannabis Inc ACB:CN CAD 1.02B 146.09M
Canopy Growth Corp WEED:CN CAD 3.02B 382.12M
Catalent CTLT:US USD 11.15B 942M
Corcept Therapeutics CORT:US USD 583.43M 50.18M
Drreddys Laboratories RDY:US INR 309.3B 18.33B
Endo International Ordinary Shares ENDP:US USD 6.01B 355.8M
GlaxoSmithKline GSK:LN GBP 60.15B 167M
Glaxosmithkline GSK:US GBP 60.15B 167M
Horizon Pharma HZNP:US USD 9.11B 86.75M
Lannett LCI:US USD 438.36M 28.94M
Novartis NOVN:VX USD 117.45B 1.01B
Pacira Pharmaceuticals PCRX:US USD 1.68B 53.16M
Perrigo Ordinary Shares PRGO:US USD 11.02B 339.8M
Phibro Animal Health PAHC:US USD 961.83M 13.46M
Prestige Brands PBH:US USD 3.75B 71.26M
Roche Holding ROG:VX 88.15B 1.42B
Supernus Pharmaceuticals SUPN:US USD 1.7B 9.38M
Takeda 4502:JP JPY 13.5T 1.08T
Teva Pharmaceutical TEVA:IT USD 44.01B 246M
Valeant Pharmaceuticals VRX:CN USD 25.69B 612M
Zoetis ZTS:US USD 14.92B 1.25B